知镜 Cognispect · 医学文献与研究工作台

Application of nanotherapy in cardiovascular diseases featuring novel pharmacological mechanisms and drug delivery strategies.

Yang J.
Discover nano · 2026-08-11 · PMID 42579251

文献摘要

Cardiovascular diseases (CVDs) remain the leading cause of death globally. However, conventional pharmacotherapy is often limited by poor targeting, low bioavailability, and systemic adverse reactions. Nanoformulations, including liposomes, polymeric nanoparticles, inorganic nanocarriers, biomimetic systems, and lipid-based carriers, have emerged as transformative platforms that enhance drug solubility, stability, and lesion-specific delivery. This review systematically summarizes the structural features, drug-loading mechanisms, and release strategies of these nanocarriers in major cardiovascular disease indications, such as atherosclerosis, myocardial infarction, hypertension, heart failure, and coronary artery disease. Relevant studies on nanoparticles loaded with Western drugs and traditional Chinese medicine monomers are discussed within a unified framework. Furthermore, this review addresses the limitations of endothelial permeability in cardiovascular tissues, translational barriers, and future directions for clinical implementation.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。